GL1X · GenesisL1 explorer

Research workbench

Recombinant horseradish peroxidase PHE209SER complex with benzhydroxamic acid

Analyse Recombinant horseradish peroxidase PHE209SER complex with benzhydroxamic acid in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1GX2
Type
protein
Length
616 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Peroxidase C1A
EC
1.11.1.7
UniProt
P00433
Ligands
HEM, BHO, CA
Pockets
4 · best druggability 0.82

Structure

x-ray diffraction · 1 distinct chain · 51% helix, 4% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BPeroxidase C1A (EC 1.11.1.7)protein30851% helix, 4% strandP00433

Ligands and binding sites

  • HEM · Protoporphyrin IX containing Fe · ligand · 2 copies · chains A, B
  • BHO · Benzhydroxamic acid · ligand · 2 copies · chains A, B
  • CA · Calcium ion · metal · 4 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111650.820.8382HEM, BHO
24450.810.8848HEM, BHO
33870.580.7543empty
4570.430.8315empty

Interfaces

1 interface between chains.

  • A–B · 468 Ų buried · 6 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 8 disulfide (disulfide).

Compared structures

  • 1GX2 · Recombinant horseradish peroxidase Phe209Ser complex with benzhydroxamic acid · the same entry in another collection · chain B against B, TM-score 1.00
  • P00433 · AlphaFold monomer V2.0 prediction for peroxidase C1A (P00433) · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.